CAM
LLY icon

Cormorant Asset Management’s Eli Lilly LLY Stock Holding History

Cormorant Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,000
Closed -$9.7M – 75
2022
Q3 		$9.7M Buy
+30,000
New +$9.51M 0.68% 40

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cormorant Asset Management's LLY Position: Q4 2022 in Review

Cormorant Asset Management sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 30,000 shares — an estimated $9.7M sold.

Cormorant Asset Management first reported a position in LLY in Q3 2022 and held it in 1 quarter. The position peaked at $9.7M in Q3 2022. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Cormorant Asset Management reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
  • Cormorant Asset Management sold 30,000 Eli Lilly shares in Q4 2022, an estimated $9.7M.
  • Cormorant Asset Management first reported a position in Eli Lilly in Q3 2022 and held it in 1 quarter.
  • Cormorant Asset Management's Eli Lilly position peaked at $9.7M in Q3 2022.
  • 2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Cormorant Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.